key: cord-0039509-kgri4myi
authors: Yuen, Kwok-Yung; Wong, Samson S. Y.; Peiris, J. S. Malik
title: The Severe Acute Respiratory Syndrome
date: 2007
journal: New and Evolving Infections of the 21st Century
DOI: 10.1007/978-0-387-32830-0_5
sha: 854a0a56b4a0f2a822b7aebf55a35bbe306e2750
doc_id: 39509
cord_uid: kgri4myi

nan

In the past century, Southern China has been the epicenter for emergence of some notable infectious diseases. The Hong Kong Special Administrative Region (HKSAR), being part of southern China, which has enjoyed a relatively more advanced public health infrastructure and international connectivity, often became the first place where such emerging infectious diseases were discovered and from where they disseminated globally. The first such example occurred in 1894 when an outbreak of plague started in Canton (now the Guangdong Province) of China. A similar outbreak, this time an acute community-acquired atypical pneumonia syndrome, occurred in the Guangdong Province in late 2002. Retrospective investigations showed that severe cases of atypical pneumonia had been recorded in five cities around Guangzhou over a period of 2 months. The index case was reported on 16 November 2002 in Foshan, a city 24 km away from Guangzhou. The second case appeared in December 2002 when a chef from Heyuan who worked in a restaurant in Shenzhen was affected. He had an occupational history of regular contact with wild-game food animals. He transmitted the disease to his wife, two sisters, and seven hospital staff who had contact with him. From 16 November 2002 to 9 February 2003, 305 cases of atypical pneumonia were reported in mainland China with 105 of them being health care workers. The link between the outbreak in mainland China and the devastating epidemics in HKSAR and the rest of the world was a professor of nephrology from a teaching hospital in Guangzhou, China. He had contact with patients suffering from this unusual atypical pneumonia between 11 and 13 February 2003, then developed flu-like symptoms, including a fever and cough, before coming to Hong Kong. He arrived in Hong Kong on 21 February and within a day transmitted infection to 16 other people in the hotel that he stayed in. Thorough investigation of this patient failed to reveal any significant pathogens. One of the secondary cases, his brother-in-law who subsequently became infected, underwent an open lung biopsy that was pivotal in the discovery of the etiology this disease. The virus was a novel coronavirus, subsequently called the severe acute respiratory syndrome (SARS) coronavirus.

Infected contacts in the hotels unknowingly carried the disease to other hospitals in the HKSAR and to other countries and continents including Vietnam, Canada, Singapore, the Philippines, the United Kingdom, the United States, and back again to China. Dr. Carlo Urbani, a physician stationed at the World Health Organization (WHO) office in Hanoi, was the first to notify the WHO of the occurrence of this disease outside Guangdong after witnessing an explosive nosocomial outbreak in a hospital in Hanoi. The index case of this outbreak was one of those who acquired infection on 21-22 February in the hotel in Hong Kong. The WHO named this "atypical pneumonia" as severe acute respiratory syndrome (SARS). Dr Urbani's description of the disease, to which he later succumbed, alerted health authorities throughout the world and started an unprecedented collaboration of 11 research laboratories in 9 countries to identify the etiological agent responsible.

SARS is essentially an acute community-acquired or nosocomial pneumonia that does not respond to conventional antimicrobial therapy for known pneumonia pathogens. As of mid-2003, 8096 cases with 774 deaths occurred on five continents (World Health Organization, 2003a) . Interpersonal transmission has occurred in health care facilities, workplaces, homes, and public transports (World Health Organization, 2003b) . From September 2003 to May 2004, three laboratory-associated outbreaks were reported Orellana, 2004) . The laboratoryacquired cases in Singapore and Taiwan were each limited to one affected person, whereas that in Beijing was associated with secondary and tertiary cases (World Health Organization, 2004) . SARS-coronavirus (SARS-CoV) is most likely zoonotic in origin and then transmitted to humans. The virus may have been circulating among wild game animals in the wet markets of southern China. The palm civet is now considered to be the most likely amplification host and one of the likely candidates for introduction to humans . A seroprevalence of about 80% was recently reported for civets in animal markets in Guangzhou (Tu et al., 2004) . The initial human cases of the 2003 pandemic and those of the 2004 Guangdong outbreak were epidemiologically linked to game animals either because of occupational contact or eating . The most important route of interpersonal spread appears to be direct or indirect contact of the mucosae with infectious respiratory droplets or fomites (World Health Organization, 2003b) . SARS-CoV has been detected in respiratory secretions, feces, urine, and tears Loon et al., 2004) . Nosocomial transmission of SARS could be facilitated by the use of nebulizers, suction, intubation, bronchoscopy, or cardiopulmonary resuscitation on SARS patients by generation of large numbers of infectious droplets Varia et al., 2003; World Health Organization 2003b; Christian et al., 2004) . Almost half of the SARS cases in Hong Kong acquired the infection within health care facilities and institutions (Leung et al., 2004a) . The overall attack rate among hospital workers is 1.2% and the attack rate was correlated with the number of SARS patients admitted (Lau et al., 2004c) . Airborne transmission is considered uncommon given the relatively low attack rates. A unique form of airborne transmission was considered the likely explanation for a large community outbreak in a private housing estate: Negative pressure generated by exhaust fans coupled with dry U traps of sewage drains was thought to facilitate the dissemination of contaminated aerosols between toilets. It is suggested that the plume of contaminated warm air along the light well was then carried by wind to other blocks of the housing complex . The finding of culturable viruses in stool and the high fecal viral load shown by quantitative reverse transcriptase polymerase chain reaction (RT-PCR) (Peiris et al., 2003a) suggested the possibility of fecal-oral transmission though this has not been proved conclusively.

The incubation period is estimated to be 2 to 14 days. Epidemiologic control measures based on the World Health Organization recommended maximal incubation period of 10 days was effective in most cases to interrupt transmission, though there had been occasionally cases in which the incubation period was found to be longer . The average number of secondary cases resulting from a single case is two to four (World Health Organization, 2003b) . Most of the transmissions resulted from contacts with patients with overt disease rather than asymptomatic or mildly symptomatic cases. Seroprevalence appeared to be low (0%, 0.43%, 1.2%) for normal individuals and about 1% for health care workers, around 1% for asymptomatic family contacts under quarantine, and 0.19% for asymptomatic contacts overall (Lee et al., 2003a; Peiris et al., 2003a; Leung et al., 2004b; Zheng et al., 2004a; . Transmission from symptomatic patients tended to occur on or after the fifth day of onset of disease, which could be explained by the rising viral load in the nasopharyngeal secretion, which peaked at around day 10. The median time for RT-PCR to convert to negative is 30 days after onset of illness and 13 days after discharge from hospital .

A definite seasonality of SARS could not be documented at this stage, though there have been correlations between the incidence of the disease and ambient temperature (Tan et al., 2005) . There was also definite geographic clustering of cases upon retrospective analysis by the geographic information system .

The family Coronaviridae consists of a group of large, enveloped, positive-sense, single-stranded RNA viruses that are of human and veterinary importance (Table 5 .1). They have the largest genome of all the RNA viruses. The SARS-CoV is one of the newly described members of the genus Coronavirus Ksiazek et al., 2003; Peiris et al., 2003b) . Primary viral isolation can be achieved by inoculating embryonal monkey cell lines such as Vero E6 and FRhK-4 cells. Subcultures can be made on other Vero cells, Huh-7 (a liver cancer cell line; Simmons et al., 2004) and CACO-2 (a colonic carcinoma cell line), and two pig cell lines (POEK, PS) (Hattermann et al., 2005) . In contrast with other human coronaviruses, SARS-CoV can be maintained in cell culture easily and it produces obvious cytopathetic effects in Vero E6 within 48 h. SARS-CoV has a higher degree of stability in the environment as compared with other known human coronaviruses World Health Organization 2003c; Rabenau et al., 2005) : it survives for at least 2 to 3 days on dry surfaces at room temperature and 2 to 4 days in stool (Rabeneu et al., 2005) .

Electron microscopy appearance and genome order ( Fig. 5 .1) of 5′replicase-structural (spike-envelope-membrane-nucleocapsid)-polyT-3′ on complete genomic sequencing are similar to other members of Coronaviridae. SARS-CoV is phylogenetically distinct from any of the three groups of known coronaviruses. Human coronaviruses 229E and NL63 belong to group 1 van der Hoek et al., 2004) ; human coronavirus OC43 belongs to group 2, and group 3 consists of all the avian coronaviruses. Phylogenetic analysis of the spike protein of 139 SARS-CoV isolates in the Hong Kong outbreak showed that several introductions had occurred but only one of them was associated with the major outbreak in Hong Kong and the rest of the world . Some of the strains found in the early stages of the outbreak were phylogenetically distinct from the major cluster and were closer to some of the Guangdong and Beijing strains. This concurred with the fact that the index patient of the Hong Kong outbreak was a Guangzhou medical doctor who had traveled to Hong Kong. Another molecular epidemiological study of a Guangdong outbreak suggested that the disease spread from Guangdong to Hong Kong and the rest of the world, and the index case was a chef who handled game animals . Subsequent animal surveillance in China recovered coronavirus isolates that have a nucleotide homology of 99.8% with the SARS-CoV . A characteristic 29-base insertion between open reading frames (ORF) 10 to 11 (also named as ORF8a and 8b) was found in these animal isolates Snijder et al., 2003) . This 29-nucleotide segment was deleted after or before crossing the species barrier to humans. The biological effect of this deletion remains elusive. A number of SARS-CoV in the later stages of the epidemic showed larger deletions around this site (The Chinese SARS Molecular Epidemiology Consortium, 2004). Two independent molecular epidemiological studies comparing the complete genome of 12 and 63 virus isolates also found evidence of a strong positive selection at the beginning of the epidemic that is followed by a purifying selection, as indicated by the amino acid substitution rate at the spike, Orf3a, and nsp3 (The Chinese SARS Molecular Epidemiology Consortium, 2004; Yeh et al., 2004; Song et al., 2005) . Both studies suggested that molecular adaptation of the virus had occurred after interspecies transmission from animals to humans. In the small outbreak of Guangzhou in 2004, all four human isolates belonged to a separate sublineage with the concurrent animal, predominantly civet cat, isolates that are distinct from the human pandemic or animal virus of the 2003. Though the SARS-CoV is distinct from the three existing groups of coronaviruses, it may be closer to group 2 because 19 out of 20 cysteines found in the S1 domain of the spike protein are spatially conserved when compared with the group 2 consensus sequence, whereas only 5 cysteine residues are conserved when compared with that of the groups 1 and 3 Snijder et al., 2003) . Because coronaviruses are believed to have co-evolved with their animal hosts, it was possible that rats, mice, and cattle harboring group 2 coronaviruses are more likely to be the animal host for SARS-CoV than cats, which harbor group 1 coronavirus. However when a comparison of the phylogenetic trees for 11 known host-species and nucleocapsid sequences of 36 coronaviruses was done using an interference approach with sliding window analysis, there is statistical incongruence that indicates multiple host-species shifts between the coronaviruses of many animals that are phylogenetically distant (Rest and Mindell, 2003) . Thus, even if the civet cats or other related mammals are the true animal reservoir rather than mice and rats, it would not be too big a surprise. Moreover, the civet cats and other related mammals had at least served as a major amplification mechanism in the markets of southern China irrespective of the original animal reservoir. The control of these animals and the markets plays a pivotal role in the epidemiological control of SARS. Genomic evidence of another animal-to-human interspecies transmission events was demonstrated in a small outbreak of four cases in early 2004 in Guangzhou (Song et al., 2005) . A metalloprotease angiotensin-converting enzyme 2 (ACE2) from Vero E6 cells was found to bind the S1 domain of the spike protein of the SARS-CoV (Li et al., 2003c) . The 293T cells transfected with ACE2 can form multinucleated syncytia with cells expressing the spike. ACE2 expression is detected by immunohistochemical staining on enterocytes, pneumocytes, vascular endothelial and smooth muscle cells. Hamming et al., 2004) . This is compatible with the clinical and histopathological manifestations of SARS, which include diffuse alveolar damage, colonic mucosal presence of abundant viral particles in a patient with diarrhea, and pulmonary vasculitis and thrombosis. The lack of virus infection in some cell lines that express ACE2 has led to a rush for finding coreceptors for cell entry . Recently, a C-type lectin called L-SIGN was shown to be an alternative receptor for binding and cell entry (Jeffers et al., 2004) , although it is not clear whether this is a functional receptor for the virus that can lead to productive virus replication. Murine ACE2 binds less efficiently with the S1 domain of SARS-CoV, and even less well with rat ACE2, which suggests that efficient replication in the mouse or rat is limited by their ACE2 type (Greenough et al., 2005) .

Pseudotyped retroviral vector carrying the S, M, or E proteins revealed that the S protein is both necessary and sufficient for virus attachment on susceptible cells (Simmons et al., 2004; Wang et al., 2004a) . Virus entry occurred via a pH-dependent receptor-mediated endocytic pathway . Pseudotyped virus carrying the S protein binds to DC-SIGN on dendritic cells, without causing cell death or replication, but this dendritic cell may serve as a conduit for infection of susceptible host cells as in the case of human immunodeficiency virus (HIV) infection. The fragment of S1-containing amino acids 270 to 510 of the S1 domain was localized to be the minimal receptor-binding region found by truncation and binding assays .

The helicase and 3CL proteinase were cloned and characterized Chou et al., 2003; Tanner et al., 2003; Yang et al., 2003) .The E (envelope) protein was found to form cation-selective ion channel in planar lipid bilayer (Wilson et al., 2004) . A molecular model of the RNA-dependent RNA polymerase has also been published , which provides clues to the functional aspect of the enzyme and therefore may facilitate the design of new antivirals in the future. Other putative targets such as the helicase (nsp13), a putative mRNA cap-1 methyltransferase (nsp16), a manganese-dependent endoribonulcease (nsp 15) (Bhardwaj et al., 2004) , and a single-stranded RNA binding protein (nsp9) are being investigated intensively by bioinformatics and crystal structure studies (Campanacci et al., 2003; von Grotthuss et al., 2003; Egloff et al., 2004) . The nomenclature of these nonstructural proteins is summarized in Table 5 .3. A full-length cDNA of the viral genome was shown to cause lytic infection in cell line with good viral titer and antigen expression (Yount et al., 2003) . This would provide the tool to study function of many nonstructural proteins by reverse genetics. 

The typical manifestation of SARS in two-thirds of the cases is that of a viral pneumonia with rapid respiratory deterioration (World Health Organization, 2003b) . The presenting symptoms are generally fever, chills, myalgia, malaise, and nonproductive cough . Rhinorrhea and sore throat are less frequently seen. Clinical deterioration often occurs 1 week after the onset of illness and may be accompanied by watery diarrhea. Physical signs on chest examination are mild when compared with the radiographical abnormalities. The chest radiograph may show ground-glass opacities and focal consolidations, typically over the periphery and often in the subpleural regions of the lower zones. Progressive involvement of both lungs may occur, as may shifting radiographic shadows and pneumomediastinum without previous use of positive pressure ventilation.

Diarrhea is the commonest extrapulmonary manifestation (Cheng et al., 2004a) , followed by hepatic dysfunction (Chau et al., 2004) , dizziness that may be related to diastolic cardiac impairment , abnormal urinalysis, petechiae , myositis (Wang et al., 2003b) , and epileptic fits (Lau et al., 2004a) . The neuromuscular abnormalities are likely to be related to critical-illness polyneuropathy and/or myopathy . The elderly patient may merely be admitted for a fall and fracture in the absence of fever or other symptoms and signs suggestive of SARS Chow et al., 2004) . Infections in children appear to be milder than in adults , whereas pregnant women infected by SARS could pose a significant management problem and carries a high case-fatality rate, although no transmission to the neonate has been documented Yudin et al., 2005) . Viral replication at different sites appears to account for the various clinical and laboratory abnormalities of SARS Farcas et al., 2005) . Nasopharyngeal and serum viral load were associated with oxygen desaturation, mechanical ventilation, and mortality ; stool viral load with diarrhea; and urine viral load with abnormal urinalysis.

Peripheral lymphocytopenia is common with or without thrombocytopenia, increases in D-dimers, and activated partial thromboplastin time. Elevated hepatic parenchymal enzymes, muscle enzymes, and lactate dehydrogenase may be seen. About 20% to 30% of the patients will deteriorate and require mechanical ventilation and the overall mortality is 15%. Death is usually related to respiratory failure, concurrent sepsis, or deterioration of underlying medical illness. Age, presence of comorbidities such as cardiac problems and diabetes mellitus, increased lactate dehydrogenase level, hypouricemia , acute renal failure , more extensive pulmonary radiological involvement at presentation , and a high neutrophil count at the time of admission are poor prognostic indicators. Most survivors have residual ground-glass opacifications on follow-up chest x-rays probably due to fibrosis. The radiological abnormalities improve with time, but advanced age, previous intensive care unit admission, mechanical ventilation, alternative treatment, higher peak lactate dehydrogenase, and the peak radiographic involvement during treatment have a positive correlation with overall reticulation and total parenchymal involvement at 6 months . Restrictive lung function abnormalities attributed to residual lung fibrosis and muscle weakness is commonly seen in the convalescent phase with an incidence of at least 20% in some studies Ong et al., 2004) . Depression and posttraumatic stress disorder are especially common in patients with affected family members and among health care workers; psychosis could be related to the use of corticosteroids and underlying predispositions . As a result of treatment with corticosteroids, a patient may have biochemical evidence of adrenal insufficiency after recovery. There is also a cumulative dose-related risk of osteonecrosis, ranging from 0.6% to 13% (Griffith at al., 2005) .

There are no pathognomonic signs or symptoms of SARS. Etiological diagnosis and differentiation from other causes of atypical pneumonia can only be made by laboratory confirmation. A positive viral culture from the respiratory, fecal, and occasionally urine specimens, a fourfold rise of neutralizing antibody titer in the serum taken on admission and 28 days afterwards are the most definitive evidence of infection. Of these methods, real-time quantitative RT-PCR of the nasopharyngeal aspirate is most practicable in aiding clinical diagnosis and can achieve a sensitivity of 80% with good specificity if it is collected within the first 3 days of illness . For antibody testing, the indirect immunofluorescent antibody test is more commonly performed than the neutralizing antibody test since the former does not involve manipulation of infectious virus and therefore carries less biohazard risk. Recombinant nucleocapsid enzyme immunoassay (EIA) can be used as a rapid screening test and possesses high sensitivity as early as 5 days after onset of illness (Che, 2004) . EIA against the nucleocapsid antigen of SARS-CoV may occasionally yield false-positive results with HCoV-OC43 and HCoV-229E and may require confirmation by Western blot against the spike polypepetide of SARS-CoV . A new immunofluorescence assay using recombinant nucleocapsid-spike fusion protein as antigen has been described . Viral load determination of nasopharyngeal specimens or serum on presentation might have clinical value as it is an important prognostic factor (Cheng et al., 2004a) .

The three laboratory outbreaks of SARS have prompted the use of pseudotype viruses for research and neutralization antibody testing.

Acute diffuse alveolar damage with airspace edema were the most prominent features in patients who died before the tenth day after onset of illness (Franks et al., 2003; Nicholls et al., 2003) . Hyaline membranes, interstitial edema, interstitial infiltrates of inflammatory cells, bronchiolar injury with loss of cilia, bronchiolar epithelial denudation, and focal deposition of fibrin on the exposed basement membranes were other observed features. Patients who died after the tenth day of illness exhibited a mixture of acute changes and the organizing phase of diffuse alveolar damage. There were interstitial and airspace fibroblast proliferation, type II pneumocyte hyperplasia, and squamous metaplasia of bronchial epithelium. The alveolar spaces contained a combination of macrophages, desquamated pneumocytes, and multinucleated cells. Hemophagocytosis in the alveolar exudates and thrombosis of venules were noted in some cases. Other pulmonary complications might include secondary bacterial bronchopneumonia and invasive aspergillosis (Wang et al., 2003a) . Systemic vasculitis involving the walls of small veins with edema, fibrinoid necrosis, and infiltration by monocytes, lymphocytes and plasma cells were noted in one report .

No tissue destruction or inflammatory process in association with viral infection were noted in other organs or tissues. Viral particles can be detected by in situ hybridization in pneumocytes and enterocytes of the small intestine . However, inflammation, cellular apoptosis, or microvilli atrophy are not found in the intestinal mucosa to account for the watery diarrhea. Immunohistochemical staining showed the presence of viral proteins in pneumocytes and occasional macrophages. Necrosis or atrophy in the lymphoid tissue of lymph nodes and white pulp of the spleen is a commonly observed extrapulmonary pathology. Flow cytometry examination of the peripheral blood at the time of admission before the use of steroid had shown decreases in levels of dendritic cell subsets, natural killer cells, CD4+ and CD8+ T lymphocytes and B lymphocytes (Cui et al., 2003; Li et al., 2004; Zhang et al., 2004b) . A study of three SARS patients suggested that a self-limiting or abortive infection of peripheral blood mononuclear cells can occur as evident by the presence of the minus-RNA, the replicative intermediate of the virus during the initial week of the illness . Study of the cytokine profile of SARS patients showed significant elevation of the plasma chemokines interleukin (IL)-8, monocyte chemotactic protein 1 (MCP-1), and interferon-gamma-inducible protein 10 (IP-10), Th1-related cytokine interferon-gamma and IL-12, and inflammatory cytokines IL-1β and IL-6, which can induce an intense inflammatory response (Jones et al., 2004; Huang et al., 2005; Jiang et al., 2005) . This may account for the recruitment and accumulation of alveolar macrophages and polymorphs and the activation of Th1 cell-mediated immunity by the stimulation of natural killer and cytotoxic T lymphocytes. In contrast, SARS-CoV appears to evade triggering an alpha and beta interferon response in human macrophages . The lack of this antiviral innate immune response may permit uncontrolled viral replication with progressive increase in viral load continuing into the second week of illness until the appearance of the adaptive immune response brings the virus replication under control. Moreover, comparative transcriptomal microarray analysis showed that the SARS-CoV rather than the HCoV-229E markedly upregulates genes associated with apoptosis, inflammation, stress response, and procoagulation during the early phase of infection of a human liver cancer cell line (Huh7). Both findings help to explain the clinical severity of SARS in relation to the high viral load up to 2 weeks of illness and the intense inflammatory response as evident from the serum cytokine profile and the histopathology .

In general, specific serum antibody by indirect immunofluorescence or neutralization test starts to appear at around day 10, plateaus at around the second month, and is maintained for more than 12 months. IgM and IgG appeared at around the same time, but the former is not detected after 2 to 3 months. Serum testing by recombinant nucleocapsid EIA can detect antibody as early as the fifth day after the onset of symptoms. Some studies have suggested a possible association of HLA-B * 4601 with susceptibility to and severity of SARS among the Chinese population in Taiwan . Among the Hong Kong Chinese population, similar associations have been found with HLA-B * 0703 .

The Koch's postulates for SARS-CoV as a causative agent of SARS was fulfilled by a primate model using cynomolgus macaques (Macaca fascicularis), which demonstrated clinical and pathological features similar to those found in humans . On the contrary, African green monkeys (Cercopithecus aethiops) did not develop significant lung pathology after inoculation with the SARS-CoV . The lack of consistency in primate animal models (rhesus, cynomolgus, and African green monkey) for experimental SARS disease was noted in a recent study . Ferrets (Mustela furo) and domestic cats (Felis domesticus) are also susceptible to infection by SARS-CoV (Martina et al., 2003) . The cats remained asymptomatic, but some of the infected ferrets died from the disease. BALB/c mice demonstrated asymptomatic infections in lungs and nasal turbinates by intranasal inoculation, in contrast with golden Syrian hamsters in which high levels of viral replication can be seen . Recently, palm civets (Paguma larvata) were shown to be susceptible to symptomatic infection by SARS coronavirus with or without the 29-bp signature sequence . Experimental infection of SARS-CoV has also been demonstrated in pigs (Weingartl et al., 2004a) . Because different SARS-CoV isolates were used by each of the groups, it is therefore uncertain whether one particular animal would be better than others as a model for SARS-CoV. However, the diverse range of mammalian species that are susceptible to experimental infection by SARS-CoV is a cause for concern. Indeed, our first report on animal SARS coronavirus showed that Chinese ferret badgers (Melogale moschata) and raccoon dogs (Nyctereutes procyonoides) could also be infected with SARS-CoV .

Clinical management of SARS relies on respiratory support and intensive care because there are no randomized clinical trials on the value of potential antiviral agents. Oxygen delivery by low-flow nasal cannula rather than the high-flow facemask should be used to minimize the risk of nosocomial airborne spread. Other modes of noninvasive ventilation such as continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BIPAP) should only be performed in negative-pressure isolation rooms with adequate personal protective equipment for the health care workers (Cheung et al., 2004) . Broad-spectrum antimicrobial coverage for community-acquired pneumonia should be given at presentation while pending virological confirmation. Nosocomial infections are important complications after prolonged intubation, hospitalization, and the use of corticosteroids.

The association between viral loads and clinical outcome raises the possibility that effective suppression of viral replication may be beneficial. In vitro susceptibility testing results were conflicting, which may partly be due to the use of different assay conditions and end-point determination. There have been contradictory results on the in vitro activities of interferon β-1a (Cinatl et al., 2003b; Hensley et al., 2004; Tan et al., 2004) and interferon α-2b (Stroher et al., 2004; Tan et al., 2004) . The antiviral effects of interferon β appeared to be mediated by mechanisms other than MxA protein (Spiegel et al., 2004) . Overall, it appears that interferon β, interferon α-n1, interferon α-n3, and leukocytic interferon α do have some activity and could be considered for further studies in clinical trials Spiegel et al., 2004; Zheng et al., 2004b) .

Some reports noted the sensitivity to ribavirin at a concentration of 200 to 1000 mg/L is related to cellular toxicity , whereas another reported that the 50% cytotoxic concentration of ribavirin exceeds 1000 mg/L (Cinatl et al., 2003a) . It is interesting to see that the same group reported good activity of ribavirin in other human and animal cell lines despite their initial report of the lack of activity of ribavirin in Vero cells .

Glycyrrhizin, baicalin (Cinatl et al., 2003a) , reserpine , niclosamide , aurintricarboxylic acid , chloroquine (Keyaerts et al., 2004) , and the protease inhibitors, especially nelfinavir (Xiong et al., 2003; Yamamoto et al., 2004) , were found to have antiviral acitivity against SARS-CoV. It is also interesting to find that an organic nitric oxide donor, S-nitro-N-acetylpenicillamine, also appeared to have inhibitory activity against SARS-CoV (Akerstrom et al., 2005) , which provides a rationale for the use of nitric oxide inhalation as a rescue therapy for SARS . Good in vitro antiviral activities have also been observed for ACE2 analogues (Towler et al., 2004) , helicase inhibitor, and nucleoside analogues screened from combinatorial chemical libraries. Synergistic activities have been seen with combinations of interferons or the above compounds with ribavirin (Cinatl et al., 2003b; The SARS-CoV spike protein uses a mechanism similar to that of class 1 fusion proteins in mediating membrane fusion and hence cell entry (Bosch et al., 2004) . Antiviral peptides designed to inhibit this claw mechanics of the spike protein might be useful in vitro (Kliger and Levanon, 2003; Liu et al., 2004) . Peptides derived from the heptad repeat 2 region of the SARS-CoV S protein were able to block viral infections Yuan et al., 2004; Zhu et al., 2004a) . siRNA designed for sequence-specific degradation of viral RNA generated during transcription demonstrated activities in reducing cytopathic effects, viral replication, and viral protein expression in cell lines. Zhang et al., 2003; Lu et al., 2004; Wang et al., 2004b; Zhang et al., 2004a; Zheng et al., 2004c) . Screening of combinatorial chemical libraries have identified inhibitors for protease, helicase, and spike-mediated cell entry .

Immunodulators have been empirically used in the treatment of SARS during the initial epidemic . These include corticosteroids, intravenous immunoglobulins, pentaglobin , thymosin, thalidomide, and anti-tumor necrosis factor. Corticosteroids have previously been used in the management of viral pneumonias due to varicella-zoster virus, influenza virus, and other viruses (Greaves et al., 1981; Ahmed et al., 2002) . Mortality in the first two infections appeared to be lower with corticosteroids than supportive treatment alone. High-dose hydrocortisone can reduce the expression of the proinflammatory chemokines CXCL8 and CXCL 10 in coronavirus-infected CACO-2 cell lines . However, unless an effective antiviral agent is available, early use of high doses of corticosteroids for prolonged period could be detrimental and may increase the risks of nosocomial infections and avasuclar bone necrosis. One study has shown that the early use of corticosteroid actually increased the plasma viral load . Pegylated interferon α-2a was shown to be useful for prophylaxis and reducing respiratory viral shedding and lung pathology when used as an early treatment in a monkey model . Combinations of steroid with either alfacon-1 (a recombinant consensus interferon-α) (Loutfy et al., 2003) or protease inhibitors and ribavirin improved outcomes in two different treatment trials using historical controls (Chan et al., 2003a; .

Passive immunization using convalescent plasma with high titers of neutralizing antibody had been used for SARS patients who continued to deteriorate. No significant adverse reactions were noted, although this did not appear to be beneficial, either. Currently, only hyperimmune globulin produced from convalescent patients' plasma and the equine plasma immunized by inactivated SARS-CoV are available for prophylactic trials in human. A human monoclonal IgG1 produced from a single-chain variable region fragment against the S1 domain from two nonimmune human antibody libraries has also been produced (Sui et al., 2004) . One of the single-chain variable region fragments 80R blocks the spike-ACE2 receptor interaction through binding to the S1 domain. In a murine model of asymptomatic SARS infection, passive immunization by high titers of neutralizing antibody prevented virus replication in the lungs but not as effectively in the nasal turbinates . Similarly, passive immunization of mice and ferrets with a human IgG1 monoclonal antibody CR3014 was effective in preventing the development of lung pathology but less effective in reducing pharyngeal excretion . Currently, there are no randomized placebo control trials on the role of antibody therapy for pre-or postexposure prophylaxis in at-risk groups during the SARS epidemic. Retrospective analysis of outcome in a human study using SARS convalescent plasma suggested that passive immunization had no major side effects and perhaps some clinical benefits (Soo et al., 2004 ). It appears that the antibody response against the viral spike antigen is the key factor for protection against infection. Similar findings were found in the murine model using either intramuscular or intranasal administration of the highly attenuated modified vaccinia virus Ankara carrying the spike protein (Bisht et al., 2004) . Mucosal immunization of African green monkeys with the recombinant attenuated parainfluenza virus-SARS-CoV spike protein chimeric virus resulted in a good neutralizing antibody response and protection from viral replication in the upper and lower respiratory tracts after live SARS-CoV challenge . Other approaches to active immunization involved the use of an adenoviral vector (carrying S, M, and N proteins) in rhesus macaques , inactivated whole virus vaccine in mice , S protein fragments in rabbits and mice (Zhang et al., 2004c) , DNA vaccination with the nucleocapsid gene in mice (Zhu et al., 2004b) ; adenoviral vector carrying the S1 domain, membrane and nucleoprotein or a DNA vaccine linking nucleocapsid protein to calreticulin (Kim et al., 2004) . A plasmid DNA vaccine carrying the spike protein encoded by humanized codons was highly protective in a mouse model . Furthermore, T-cell depletion with specific monoclonal antibodies against CD4 or CD8, alone or in combination with CD90 did not affect the protective immunity, which was confirmed by adoptive T-cell transfer. Donor T cells alone did not inhibit pulmonary viral replication in recipient mice, whereas passive transfer of purified IgG from immunized mice achieved similar protection. In summary (Table 5. 3), all vaccines based on the spike protein appeared to be capable of inducing neutralizing antibody responses, and those carrying nucleoprotein induced nucleoproteinspecific cell-mediated immunity.

The relative importance of systemic or mucosal immunity in terms of neutralizing antibody or cytotoxic T lymphocyte response against spike, nucleocapsid, or other targets in terms of recovery from SARS is unknown. Nevertheless, neutralizing antibody against spike appears to be crucial for prophylactic immunity. Live-attenuated virus is unlikely to be useful owing to the concern for reversion to virulence or recombination with wild strains to form new wild types. An inactivated SARS-CoV is the most likely candidate for clinical trials. Recombinant proteins expressed in mammalian cells can also be used to induce good neutralizing antibody response. Irrespective of the approach to immunization, one should bear in mind the phenomenon of immune enhancement of disease has occurred in feline peritonitis coronavirus infection. SARS-CoV vaccine may indeed lead to increased derangement in the liver function of challenged ferrets that had previously been vaccinated (Weingartl et al., 2004b) . Atypical or a more severe form of disease had occurred after the use of inactivated measles and respiratory syncytial virus vaccination. The economic viability of SARS vaccine depends very much on the risk of having another SARS epidemic and future major antigenic variations that might appear.

Infection control against SARS is of paramount importance within health care facilities given the relative stability of SARS-CoV in the environment, absence of protective immunity in the general population, and the lack of effective antivirals or vaccines. Triage of suspected cases, early case detection, and prompt isolation of suspected cases are the principal measures against nosocomial transmission . Respiratory droplet and contact precautions are effective under most circumstances . Airborne precautions must be considered in situations where droplet nuclei are likely to be generated. Strict hand hygiene, preferably with a patrol nurse overseeing all gowning and degowning procedures, in a SARS ward are critically important. Contact tracing, quarantine of contacts to prevent community spread, temperature checks at borders, health declarations for travelers, public education and effective risk communication with public media were all used in the 2003 pandemic for effective control. All SARS laboratories must strictly comply with the World Health Organization standards, and live viruses should only be cultivated and handled in accredited biosafety level 3 laboratories. Daily checking of temperature and reporting of sickness should be part of the monitoring protocol for laboratory workers handling live viruses.

Although screenings at international borders and airports were widely practiced during the epidemic, the value of such screening has recently been questioned (St John et al., 2005) . Nevertheless, travelers during the epidemic may be less vigilant on preventive measures against the disease, and they remain an important target in the prevention of cross-border spread of the infection (Lau et al., 2004b) .

Varicella pneumonia: another "steroid responsive" pneumonia?

Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor

The severe acute respiratory syndrome coronavirus Nsp15 protein is an endoribonuclease that prefers manganese as a cofactor

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS

Structural genomics of the SARS coronavirus: cloning, expression, crystallization and preliminary crystallographic study of the Nsp9 protein

Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study

SARS: prognosis, outcome and sequelae

Tears and conjunctival scrapings for coronavirus in patients with SARS

Epidemiologic linkage and public health implication of a cluster of severe acute respiratory syndrome in an extended family

SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases

Nucleocapsid protein as early diagnostic marker for SARS

In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds

Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in Beijing

Anti-SARS-CoV immunoglobulin G in health care workers

Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region

Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome

Medical treatment of viral pneumonia including SARS in immunocompetent adult

Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis

Effectiveness of noninvasive positive pressure ventilation in the treatment of acute respiratory failure in severe acute respiratory syndrome

Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China

Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS

Outbreak of severe acute respiratory syndrome in a tertiary hospital in Singapore, linked to an index patient with atypical presentation: epidemiological study

Possible SARS coronavirus transmission during cardiopulmonary resuscitation

Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings

Initial viral load and the outcomes of SARS

Duration of RT-PCR positivity in severe acute respiratory syndrome

Acute renal impairment in coronavirus-associated severe acute respiratory syndrome

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

Treatment of SARS with human interferons

High-dose hydrocortisone reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10 in SARS coronavirusinfected intestinal cells

Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome

The clinical pathology of severe acute respiratory syndrome (SARS): a report from China

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation

The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world

Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus

A previously undescribed coronavirus associated with respiratory disease in humans

Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore

Effects of a SARS-associated coronavirus vaccine in monkeys

A possible role for corticosteroids in the treatment of influenzal pneumonia

Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice

Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Susceptibility of different eukaryotic cell lines to SARS-coronavirus

Inhibition of SARS-associated coronavirus infection and replication by RNA interference

Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid

Novel immunofluorescence assay using recombinant nucleocapsid-spike fusion protein as antigen to detect antibodies against severe acute respiratory syndrome coronavirus

Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry

Interferon-beta 1a and SARS coronavirus replication

Pentaglobin in steroid-resistant severe acute respiratory syndrome

SARS: hospital infection control and admission strategies

Coronaviruses

An interferon-gamma-related cytokine storm in SARS patients

Severe acute respiratory syndrome: correlation between clinical outcome and radiologic features

Viral loads in clinical specimens and SARS manifestations

Spike glycoprotein cleavage recognition site analysis of infectious bronchitis virus

CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus

Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids

Identification of novel small molecule inhibitors of severe acute respiratory syndromeassociated coronavirus by chemical genetics

In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine

Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus

Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy

Analysis of cellular receptors for human coronavirus OC43

A novel coronavirus associated with severe acute respiratory syndrome

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome

Severe acute respiratory syndrome can be mild in children

Understanding the spatial clustering of severe acute respiratory syndrome (SARS) in Hong Kong

Possible central nervous system infection by SARS coronavirus

SARS related preventive and risk behaviours practised by Hong Kong-Mainland China cross border travellers during the outbreak of the SARS epidemic in Hong Kong

SARS in three categories of hospital workers

Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study

Asymptomatic severe acute respiratory syndrome-associated coronavirus infection

A major outbreak of severe acute respiratory syndrome in Hong Kong

Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients

Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection

The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients

SARS-CoV antibody prevalence in all Hong Kong patient contacts

SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients

Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome

Laboratory-acquired severe acute respiratory syndrome

Association of HLA class I with severe acute respiratory syndrome coronavirus infection

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors

The severe acute respiratory syndrome coronavirus in tears

Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study

Attenuation of SARS coronavirus by a short hairpin RNA expression plasmid targeting RNA-dependent RNA polymerase

Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys

SARS virus infection of cats and ferrets

Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines

Association of human-leukocyte-antigen class I (B * 0703) and class II (DRB1 * 0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome

Six month radiological and physiological outcomes in severe acute respiratory syndrome (SARS) survivors

Lung pathology of fatal severe acute respiratory syndrome

Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome

Laboratory-acquired SARS raises worries on biosafety

Studies on avian infectious bronchitis virus (IBV). II. Propagation of IBV in several cultured cells

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

Coronavirus as a possible cause of severe acute respiratory syndrome

Early diagnosis of SARS coronavirus infection by real time RT-PCR

Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice

Stability and inactivation of SARS coronavirus

SARS associated coronavirus has a recombinant polymerase and coronaviruses have a history of host-shifting

Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS)

Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoproteinmediated viral entry

Unique and conserved features of genome and proteome of SARScoronavirus, an early split-off from the coronavirus group 2 lineage

Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human

Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients

The antiviral effect of interferonbeta against SARS-coronavirus is not mediated by MxA protein

Border screening for SARS

Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-alpha

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs

An initial investigation of the association between the SARS outbreak and weather: with the view of the environmental temperature and its variation

Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice

Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E

The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5′ to 3′ viral helicases

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets

Mechanisms and enzymes involved in SARS coronavirus genome expression

Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2)

Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases

ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

Neuromuscular disorders in severe acute respiratory syndrome

A cluster of cases of severe acute respiratory syndrome in Hong Kong

Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus

Identification of a new human coronavirus

Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto

mRNA cap-1 methyltransferase in the SARS genome

Fatal aspergillosis in a patient with SARS who was treated with corticosteroids

Rhabdomyolysis associated with probable SARS

Expression cloning of functional receptor used by SARS coronavirus

Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system

Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells

Susceptibility of pigs and chickens to SARS coronavirus

Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets

SARS coronavirus E protein forms cation-selective ion channels

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome

Severe acute respiratory syndrome (SARS) in a geriatric patient with a hip fracture. A case report

Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome

Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia

False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide

Summary of probable SARS cases with onset of illness from 1

Consensus document on the epidemiology of severe acute respiratory syndrome (SARS)

First data on stability and resistance of SARS coronavirus compiled by members of WHO laboratory network

SARS situation update 5

Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide

Small molecules targeting severe acute respiratory syndrome human coronavirus

Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates

Haemorrhagic-fever-like changes and normal chest radiograph in a doctor with SARS

Renal hypouricemia is an ominous sign in patients with severe acute respiratory syndrome

A 3D model of SARS-CoV 3CL proteinase and its inhibitors design by virtual screening

Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design

Crystal structure of SARS-CoV spike protein fusion core

HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

pHdependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution

Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus

Evidence of airborne transmission of the severe acute respiratory syndrome virus

Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein

Severe acute respiratory syndrome in pregnancy

Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments

Inhibiting severe acute respiratory syndrome-associated coronavirus by small interfering RNA

Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference

Characterization of peripheral dendritic cell subsets and its implication in patients infected with severe acute respiratory syndrome

Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies

Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine

SARS-related virus predating SARS outbreak

Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma)

Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus

Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China

Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors

Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine